Oppenheimer Asset Management Inc. grew its stake in shares of Silicon Laboratories Inc. (NASDAQ:SLAB – Free Report) by 1.4% during the 4th quarter, Holdings Channel.com reports. The firm owned 7,169 shares of the semiconductor company’s stock after buying an additional 102 shares during the quarter. Oppenheimer Asset Management Inc.’s holdings in Silicon Laboratories were worth $891,000 as of its most recent SEC filing.
Other institutional investors have also recently made changes to their positions in the company. Advisors Asset Management Inc. raised its holdings in shares of Silicon Laboratories by 159.4% during the third quarter. Advisors Asset Management Inc. now owns 275 shares of the semiconductor company’s stock valued at $32,000 after purchasing an additional 169 shares during the period. International Assets Investment Management LLC raised its holdings in shares of Silicon Laboratories by 11,457.1% during the third quarter. International Assets Investment Management LLC now owns 809 shares of the semiconductor company’s stock valued at $93,000 after purchasing an additional 802 shares during the period. Venturi Wealth Management LLC raised its holdings in shares of Silicon Laboratories by 207.0% during the fourth quarter. Venturi Wealth Management LLC now owns 786 shares of the semiconductor company’s stock valued at $98,000 after purchasing an additional 530 shares during the period. Asset Management One Co. Ltd. acquired a new position in shares of Silicon Laboratories during the fourth quarter valued at about $117,000. Finally, KBC Group NV raised its holdings in shares of Silicon Laboratories by 42.1% during the fourth quarter. KBC Group NV now owns 1,279 shares of the semiconductor company’s stock valued at $159,000 after purchasing an additional 379 shares during the period.
Insider Activity at Silicon Laboratories
In related news, Director William G. Bock sold 1,000 shares of the company’s stock in a transaction that occurred on Tuesday, February 18th. The shares were sold at an average price of $149.43, for a total transaction of $149,430.00. Following the sale, the director now directly owns 31,115 shares in the company, valued at approximately $4,649,514.45. This represents a 3.11 % decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Also, Director Navdeep S. Sooch sold 2,360 shares of the company’s stock in a transaction that occurred on Wednesday, February 5th. The shares were sold at an average price of $149.00, for a total transaction of $351,640.00. Following the sale, the director now owns 400,567 shares in the company, valued at $59,684,483. The trade was a 0.59 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 5,360 shares of company stock worth $782,610. 1.72% of the stock is owned by corporate insiders.
Silicon Laboratories Price Performance
Silicon Laboratories (NASDAQ:SLAB – Get Free Report) last released its earnings results on Tuesday, February 4th. The semiconductor company reported ($0.11) earnings per share for the quarter, meeting analysts’ consensus estimates of ($0.11). Silicon Laboratories had a negative net margin of 32.69% and a negative return on equity of 10.46%. The firm had revenue of $166.25 million during the quarter, compared to the consensus estimate of $166.09 million. During the same period in the prior year, the firm earned ($1.19) EPS. The company’s revenue was up 91.4% compared to the same quarter last year. Equities analysts expect that Silicon Laboratories Inc. will post -0.97 EPS for the current fiscal year.
Analyst Upgrades and Downgrades
Several research firms have recently commented on SLAB. Needham & Company LLC boosted their target price on shares of Silicon Laboratories from $140.00 to $150.00 and gave the stock a “buy” rating in a research report on Wednesday, February 5th. Stifel Nicolaus boosted their target price on shares of Silicon Laboratories from $135.00 to $145.00 and gave the stock a “buy” rating in a research report on Monday, January 6th. Barclays boosted their target price on shares of Silicon Laboratories from $75.00 to $120.00 and gave the stock an “equal weight” rating in a research report on Friday, January 17th. StockNews.com downgraded shares of Silicon Laboratories from a “hold” rating to a “sell” rating in a research report on Friday, February 28th. Finally, Susquehanna began coverage on shares of Silicon Laboratories in a research report on Tuesday, December 17th. They set a “neutral” rating and a $130.00 target price for the company. One equities research analyst has rated the stock with a sell rating, five have given a hold rating and six have assigned a buy rating to the company’s stock. According to data from MarketBeat, the stock presently has a consensus rating of “Hold” and an average target price of $136.20.
Silicon Laboratories Profile
Silicon Laboratories Inc, a fabless semiconductor company, provides various analog-intensive mixed-signal solutions in the United States, China, Taiwan, and internationally. The company's products include wireless microcontrollers and sensor products. Its products are used in various electronic products in a range of applications for the industrial Internet of Things (IoT), including industrial automation and control, smart buildings, access control, HVAC control, and industrial wearables and power tools; smart cities applications, such as smart metering, smart street lighting, renewable energy, electric vehicle supply equipment, and smart agriculture; commercial IoT applications, including smart lighting, asset tracking, electronic shelf labels, theft protection, and enterprise access points; smart home applications, comprising home automation/security systems, smart speakers, smart lighting, HVAC control, smart cameras, smart appliances, smart home sensing, smart locks, and window/blind controls; and connected health applications, including diabetes management, consumer health and fitness, elderly care, patient monitoring, and activity tracking; as well as in commercial building automation, consumer electronics, and medical instrumentation.
Featured Articles
- Five stocks we like better than Silicon Laboratories
- What is the Australian Securities Exchange (ASX)
- GitLab: Get In While It’s Down—Big Rebound Ahead
- How to Invest in the FAANG Stocks
- Tesla Stock: Finding a Bottom May Take Time
- Low PE Growth Stocks: Unlocking Investment Opportunities
- Duolingo: This Beaten-Down Stock Is About to Rally 38%
Want to see what other hedge funds are holding SLAB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Silicon Laboratories Inc. (NASDAQ:SLAB – Free Report).
Receive News & Ratings for Silicon Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Silicon Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.